Susquehanna Has Lowered Expectations for Astera Labs (NASDAQ:ALAB) Stock Price

Key Points

• Susquehanna cut its Astera Labs price target to $258 from $310 and maintained a neutral rating, implying about 10.4% upside from the prior close.
• Analyst views remain mixed: MarketBeat reports a “Moderate Buy” consensus and a $331.47 average target, with 12 Buy ratings and 10 Hold ratings.
• Astera Labs beat quarterly estimates, posting $1.32 per share in earnings and $584.9 million in revenue; revenue rose 153.6% year over year.

Astera Labs (NASDAQ:ALAB - Get Free Report) had its target price dropped by Susquehanna from $310.00 to $258.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has a "neutral" rating on the stock. Susquehanna's target price points to a potential upside of 10.44% from the stock's previous close.

Other analysts also recently issued research reports about the stock. TD Cowen decreased their price target on shares of Astera Labs from $375.00 to $300.00 and set a "hold" rating for the company in a research report on Monday, October 19th. Jefferies Financial Group upped their price target on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. Needham & Company LLC reduced their price objective on shares of Astera Labs from $425.00 to $300.00 and set a "buy" rating on the stock in a research note on Wednesday. Barclays raised their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a report on Monday, July 20th. Finally, Roth Capital reissued a "buy" rating and issued a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Twelve investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, Astera Labs has a consensus rating of "Moderate Buy" and an average price target of $331.47.

Astera Labs Stock Up 1.7%

Shares of NASDAQ ALAB opened at $233.62 on Wednesday. Astera Labs has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The business has a 50 day moving average price of $306.13 and a two-hundred day moving average price of $255.53. The firm has a market cap of $40.53 billion, a PE ratio of 115.65 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The company had revenue of $584.90 million for the quarter, compared to the consensus estimate of $550.78 million. During the same period in the previous year, the business earned $0.49 EPS. Astera Labs's revenue for the quarter was up 153.6% compared to the same quarter last year. On average, analysts anticipate that Astera Labs will post 2.71 earnings per share for the current year.

Insider Activity

In other Astera Labs news, Director Stefan Dyckerhoff sold 8,994 shares of the company's stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $2,472,990.24. Following the completion of the transaction, the director owned 3,309 shares in the company, valued at approximately $909,842.64. This represents a 73.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares of the company's stock, valued at $32,872,551. This trade represents a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock worth $127,306,034 over the last three months. Insiders own 10.40% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Amazon Com Inc. acquired a new stake in Astera Labs in the second quarter worth about $134,172,000. Edgestream Partners L.P. acquired a new position in Astera Labs during the 1st quarter valued at about $1,891,000. Lido Advisors LLC increased its stake in Astera Labs by 123.4% during the 1st quarter. Lido Advisors LLC now owns 27,477 shares of the company's stock valued at $3,012,000 after buying an additional 15,180 shares during the period. Silvant Capital Management LLC bought a new stake in shares of Astera Labs during the 2nd quarter worth about $11,277,000. Finally, Sanders Morris Harris LLC bought a new stake in shares of Astera Labs during the 3rd quarter worth about $4,821,000. Institutional investors own 60.47% of the company's stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported record Q3 revenue of $584.9 million, up 49% quarter over quarter and 154% year over year. Adjusted earnings of $1.32 per share beat the $1.19 consensus estimate, as did revenue versus expectations of $550.78 million. Astera Labs Reports Third Quarter 2026 Financial Results
• Positive Sentiment: Growth was led by the Scorpio fabric-switch family, now Astera Labs’ largest product line, with volume production of the Scorpio X-Series 320-lane switch. The company also expanded products for memory, optical and copper connectivity, and rack-scale AI systems—supporting its opportunity in AI infrastructure. Q3 2026 Earnings Call Highlights
• Positive Sentiment: Reports said the company’s forward guidance also topped estimates, adding to the earnings beat and potentially reinforcing expectations for continued demand. Astera Labs Q3 Results and Guidance
• Negative Sentiment: The results arrive after a sharp retreat: a recent report said ALAB had fallen about 54% from its year-to-date high and broken below key support. That weakness may keep volatility elevated and leave investors focused on whether earnings growth can restore confidence. Astera Labs Stock and Key Support

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.